⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26252238 | 1.00 | — | — | |
| SCHEMBL21227330 | 1.00 | — | — | |
| SCHEMBL27657813 | 0.86 | — | — | |
| SCHEMBL3850142 | 0.85 | — | — | |
| SCHEMBL28005930 | 0.82 | — | — | |
| SCHEMBL3630558 | 0.79 | — | — | |
| SCHEMBL22386664 | 0.79 | — | — | |
| SCHEMBL30277969 | 0.76 | L3MBTL1 (0.32) | — | |
| SCHEMBL21962594 | 0.74 | L3MBTL1 (0.31) | — | |
| SCHEMBL31149439 | 0.74 | SCN1A (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569383-B2 | Utilization of rhinologically active substances | SYMRISE AG (DE) | 2013-10-29 | — | — | US | claimed |
| EP-1341512-B1 | RHINOLOGICAL AGENTS | SYMRISE GMBH & CO KG (DE) | 2008-12-31 | — | — | EP | claimed |
| US-20080274064-A1 | UTILIZATION OF RHINOLOGICALLY ACTIVE SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-11-06 | — | — | US | claimed |
| US-7414079-B2 | Utilization of rhinologically active substances | SYMRISE GMBH & CO. KG (DE) | 2008-08-19 | — | — | US | claimed |
| US-20050027017-A1 | Rhinologically active substances | SYMRISE AG (DE) | 2005-02-03 | — | — | US | claimed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | disclosed |
| US-12421480-B2 | Core-shell capsules prepared with linear and cyclic aliphatic polyisocyanates | SYMRISE AG (DE) | 2025-09-23 | — | — | US | disclosed |
| EP-3898910-B1 | ALICYCLIC MUSK FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2025-09-03 | — | — | EP | disclosed |
| EP-3880777-B1 | PERFUMING INGREDIENTS WITH LILY OF THE VALLEY NOTE | SYMRISE AG (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-20250144589-A1 | Method for Producing Microcapsules | SYMRISE AG (DE) | 2025-05-08 | — | — | US | disclosed |
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| US-20080274064-A1 | UTILIZATION OF RHINOLOGICALLY ACTIVE SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-11-06 | — | — | US | disclosed |
| US-7414079-B2 | Utilization of rhinologically active substances | SYMRISE GMBH & CO. KG (DE) | 2008-08-19 | — | — | US | disclosed |
| US-20080175800-A1 | USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-07-24 | — | — | US | disclosed |
| US-20080096969-A1 | N alpha-(Menthanecarbonyl)amino acid amides and use thereof as physiological cooling active ingredients | SYMRISE GMBH & CO. KG (DE) | 2008-04-24 | — | — | US | disclosed |
| US-20080095719-A1 | Blackberry Extract | SYMRISE GMBH & CO. KG (DE) | 2008-04-24 | — | — | US | disclosed |
| US-20080085246-A1 | Use of Eugenol Acetate as an Agent Against Bad Breath | SYMRISE GMBH & CO. KG (DE) | 2008-04-10 | — | — | US | disclosed |
| US-20070218016-A1 | Use of Aroma Substance Mixtures as Agents Against Bad Breath | SYMRISE GMBH & CO. KG (DE) | 2007-09-20 | — | — | US | disclosed |
| US-20050027017-A1 | Rhinologically active substances | SYMRISE AG (DE) | 2005-02-03 | — | — | US | disclosed |